Creating a safe CAR T-Cell therapy to fight solid tumors in children – Medical Xpress

Chimeric Antigen Receptor T-cell therapyCAR Thas revolutionized leukemia treatment. Unfortunately, the therapy has not been effective for treating solid tumors including childhood cancers such as neuroblastoma. Preclinical studies using certain CAR T against neuroblastoma revealed toxic effects. Now, a group of scientists at Children’s Hospital Los Angeles have developed a modified version of CAR T that shows promise in targeting neuroblastoma, spares healthy brain tissue and more effectively kills…

Click here to view the original article.